Animal Model Development

It is crucial to establish suitable animal models in order to evaluate the possible therapeutic and preventative effects of antiviral medications and vaccinations.

We are a leader in preclinical drug discovery and can provide full-service SARS-CoV-2 model development services involving many species. Our expert scientists might collaborate and assist with clients worldwide in creating suitable rodent and non-human primate (NHP) models for conducting research on medicinal countermeasures. The hypothesis that the possible receptor of SARS-CoV-2 could be angiotensin-converting enzyme 2 (ACE2) gives our investigators a direction to build the transgenic animal model. Specifically, the knowledge gained from building transgenic models for SARS-CoV and MERS-CoV will significantly speed up the development of transgenic animal models.